Inflation concerns trigger a market dip as new data shows impact of Trump tariffs in June
President Donald Trump's tariff campaign is coming for your price tags. On Tuesday, the Labor Department released new data on its Consumer Price Index, showing that consumer prices rose 2.7% in June from a year earlier, and faster than May's increase of 2.4%. Though that increase was in line with economists' expectations, the stock market still reacted negatively to the news, with the S&P 500 dropping 0.4% and the Dow losing nearly 1%.
Markets have been on a rollercoaster since Trump unveiled his aggressive plans at April's Liberation Day announcement, though stocks have mostly recovered since a calamitous collapse in the spring. But with Trump once again threatening an aggressive hike on trading partners' levies on Aug. 1, and the existing tariffs already impacting consumer goods, volatility is likely still on the horizon for investors.
The Consumer Price Index, which tracks goods and services costs, is a reliable tracker for measuring inflation, with investors often turning to updated data to predict potential macroeconomic changes, such as Federal Reserve rate cuts. Though CPI has been trending downward since a peak in 2022, a reversal could prolong cuts, especially with Federal Reserve Chair Jerome Powell warning that Trump's tariffs are likely to negatively impact inflation, much to Trump's chagrin.
The new data on Tuesday triggered mixed results for stocks, with banks like Wells Fargo and JPMorgan dropping despite better-than-expected earnings results. Nvidia, the first $4 trillion company, rose on Tuesday after announcing it hoped to resume sales of certain general processing units to China, which had been previously restricted due to export controls.
Tuesday's dip in the S&P 500 demonstrated that investors are still waiting ahead of Trump's new tariff deadline of Aug. 1, which would impose steep import costs on dozens of U.S. trading partners. Still, JP Morgan's U.S. head of investment strategy, Jacon Manoukian, told Fortune that he remains confident in the U.S. economy's long-term dominance, describing the so-called 'Sell America' trade as short-sighted. 'We completely disagree with the idea that the U.S. is somehow losing its position as the center of the financial universe,' he said.
Other assets also fell on Tuesday, with Bitcoin's hot streak cooling down as the top cryptocurrency fell around 2.9% at the time of publication. It dropped below its new benchmark of $120,000, though it still remained above $115,000. But that could change as the House of Representatives continues with its self-announced 'Crypto Week,' as lawmakers consider different bills that would establish regulatory frameworks for stablecoins and other cryptocurrencies. Circle, the stablecoin company that went public in June, fell about 4.6% on Tuesday.
This story was originally featured on Fortune.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Open Sauce's Eye-catching Creations? Meet Elegoo's AI Robots, Glowing Cosplay Wings, and More, All 3D Printed
SAN FRANCESCO, July 18, 2025 /PRNewswire/ -- Elegoo, a rapidly developing brand in global smart manufacturing, joins Open Sauce today, one of the world's biggest gatherings of makers, creators, and tech innovators - at Booth A15 and A16, the San Mateo County Event Center. During the 3-day event from July 18 to July 20 in San Francisco, Elegoo is unveiling a lineup of 3D printed creations built around STEM ideas and co-created with creators worldwide. "We're here at Open Sauce because it celebrates the maker spirit we believe in," said Coco Lee, Brand Director at Elegoo. "This isn't just a place to show off tech - it's where people come to make it their own. We're here to co-create, spark ideas, explore collaborations, and most of all, deliver the fun and wonder of 3D printing." Elegoo for the first time presents some of the coolest creations including: Open-source AI robot fleet of nine: 3D printed by Elegoo's passionate engineers, these robots run on the ESP32-S3 chip and draw inspiration from the Otto robot and the open-source XiaoZhi AI project. Elegoo expanded on this idea by 3D printing custom shells, while redesigning the control board and rewriting the firmware to create their own version. The robots can listen, speak, display expressions, take photos, perform movements as instructed, and interpret user intent through AI with the help of sensors. This open-source foundation blends 3D printing, AI, and robotics into one accessible platform, inspiring developers around the world. Animatronic Wings: Co-created with Willow Creative in just four weeks, this project turns heads and shows the power of 3D printing. Most parts, including feathers, hinges, connectors, and backpack frame, are 3D printed with the OrangeStorm Giga and Centauri Carbon. Each feather is made of transparent PETG to work with addressable 3mm LED strips, allowing for dynamic light effects. Tipsy: Totally Intelligent Pouring System (Tipsy) is an AI-powered drink pouring machine created by Concept Bytes, with support from Elegoo for 3D printers and materials. Its entire outer casing is 3D printed. The machine connects up to 12 drink sources via tubing and uses small pumps to precisely dispense single or double shots. A digital control panel displays ChatGPT-generated drink images, adding a fun and customizable touch. Tipsy is fully open-source and was made using the Centauri Carbon. GlowGear: A futuristic cosplay sword created in collaboration with Little Jem. It features smoke effects and sound, and was printed on the Centauri Carbon with 120 hours of print time. Besides exciting projects, visitors can experience Elegoo's latest 3D printers, including the Centauri Carbon and Jupiter 2, and enjoy interactive games and giveaways at the booth. For more information, please follow Elegoo's social media platforms, including Facebook, Instagram, X, YouTube, TikTok, Discord, and Reddit. Event Details: Date: July 18-20, 2025Location: San Mateo County Event Center, 1346 Saratoga Dr, San Mateo, CA, USBooth: A15, 16 About Elegoo Founded in 2015, Elegoo is a rapidly developing brand in the global smart manufacturing industry, specializing in R&D, manufacturing, and sales of consumer-grade 3D printers, laser engravers, STEM kits, and other smart technology products. Located in Shenzhen, the Silicon Valley of China, the company has sold millions of products across more than 100 countries and regions. In 2024, the company's total sales revenue surpassed 220 million USD, with more than 1000 employees and nearly 30,000 square meters of office and manufacturing area. With a focus on programming and 3D printing technology, Elegoo provides unique and smart creation spaces for diverse consumers to enhance personalized experiences. View original content to download multimedia: SOURCE ELEGOO
Yahoo
26 minutes ago
- Yahoo
Why Income Investors Are Watching Bristol-Myers Squibb Company (BMY) in 2025
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. A pharmacy shelves stocked with pharmaceutical drugs awaiting distribution. The company has dealt with some hurdles in the past, but it has secured several key new drug approvals in recent years. One of the most notable is Reblozyl, a treatment for anemia in individuals with beta-thalassemia, a rare blood disorder. In the first quarter, Reblozyl generated $478 million in sales, marking a 35% increase compared to the same period last year. Bristol-Myers Squibb Company (NYSE:BMY)'s revenue for the year came in at $11.2 billion, which, though, fell by 5.6% from the same period last year, beat analysts' estimates by $494.6 million. The company's cash position also remained strong, with cash and cash equivalents of $10.9 billion, up from $10.34 billion at the end of December 2024. Bristol-Myers Squibb Company (NYSE:BMY) has raised its full-year revenue forecast from around $45.5 billion to a new range of about $45.8 billion to $46.8 billion. This upward revision reflects strong results from its Growth Portfolio, stronger-than-anticipated Legacy Portfolio sales in the first quarter of 2025, and a positive foreign exchange impact of roughly $500 million. Bristol-Myers Squibb Company (NYSE:BMY) offers a quarterly dividend of $0.62 per share and has a dividend yield of 5.18%, as of July 17. The company has been rewarding its shareholders with growing dividends for the past 16 years. While we acknowledge the potential of BMY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Is AstraZeneca (AZN) a Reliable Dividend Stock for Long-Term Investors?
AstraZeneca PLC (NASDAQ:AZN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. A pharmacy worker distributing prescription medicines to patientsreceiving treatment for oncology, cardiovascular, renal, metabolism and respiratory diseases. AstraZeneca PLC (NASDAQ:AZN) has a strong lineup of drugs in development, which should help it navigate upcoming patent expirations. By the end of the first quarter, it had secured around 13 drug approvals or label updates. Among its most promising experimental treatments are two potential weight management drugs, AZD5004 and AZD6234. Overall, the company is working on nearly 200 programs in its research pipeline. In the first quarter of 2025, AstraZeneca PLC (NASDAQ:AZN) reported revenue of $13.6 billion, which showed a 7% growth from the same period last year. Total revenue has grown across all key regions, with core operating profit rising by 12%. The company is also planning to ramp up its investment in manufacturing and research in the U.S., building on its major R&D centers in Gaithersburg, Maryland, and Cambridge, Massachusetts. Overall, it is steadily moving closer to its goal of reaching $80 billion in total revenue by 2030. AstraZeneca PLC (NASDAQ:AZN) currently pays an interim dividend of $1.03 per share and has a dividend yield of 2.25%, as of July 17. It is one of the best dividend stocks in the pharma sector as the company has been paying regular dividends to shareholders for the past 32 years. While we acknowledge the potential of AZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio